Therapy of Vasovagal Syncope: Is There a Role for Drugs Today?

  • R. Sutton
Conference paper


Treatment of vasovagal syncope usually demands no more than explanation and reassurance. However, if symptoms are frequent, severe and distressing and have not responded to the initial conservative measures, the physician’s thoughts naturally turn to drugs.


Selective Serotonin Reuptake Inhibitor Vasovagal Syncope Drug Today Neurocardiogenic Syncope Paroxetine Hydrochloride 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sander-Jensen K, Secher NH, Astrup A et al (1986) Hypotension induced by passive head-up tilt: endocrine and circulatory mechanisms. Am J Physiol 251:R743–749Google Scholar
  2. 2.
    Fitzpatrick A, Williams T, Ahmed R et al (1992) Echocardiographic and endocrine changes during vasovagal syncope induced by prolonged head-up tilt. Eur J Card Pacing Electrophysiol 2:121–128Google Scholar
  3. 3.
    Klingenheben T, Kalusche D, Li Y-G et al (1996) Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardio-genic syncope: correlation with successful therapy with ß-receptor antagonist. J Cardiovasc Electrophysiol 7:802–808PubMedCrossRefGoogle Scholar
  4. 2.
    Fitzpatrick AP, Ahmed R, Williams S, Sutton R (1991) A randomised trial of medical therapy in ‘malignant vasovagal or neurally mediated bradycardia/hypotension syndrome’. Eur J Card Pacing Electrophysiol 1:99–102Google Scholar
  5. 5.
    Brignole M, Menozzi C, Gianfranchi L et al (1992) A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 70:339–342PubMedCrossRefGoogle Scholar
  6. 6.
    Mahanonda N, Bhuripanyo K, Kangkagate C et al (1995) Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table results. Am Heart J 130:1250–1253PubMedCrossRefGoogle Scholar
  7. 7.
    Sutton R, Brignole M, Menozzi C et al (2000) Dual chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicenter randomized study. Circulation 102:294–299PubMedCrossRefGoogle Scholar
  8. 8.
    Scott W A, Giacomo P, Bromberg BI et al (1995) Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 76:400–402PubMedCrossRefGoogle Scholar
  9. 9.
    Kurbaan AS, Wijesekera N, Franzen A-C et al (2001) Age related differences in underlying pathophysiology of suspected vasovagal syncope. J Am Coll Cardiol 37:146A(abstr)CrossRefGoogle Scholar
  10. 10.
    Madrid AH, Ortega J, Rebollo RG et al (2001) Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective double blind, randomised and placebo controlled study. J Am Coll Cardiol 37:554–559PubMedCrossRefGoogle Scholar
  11. 11.
    Morillo C, Leitch J, Yee R, Klein GJ (1993) A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 22:1843–1848PubMedCrossRefGoogle Scholar
  12. 12.
    Milstein S, Buetikofer J, Donnigan A et al (1990) Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 65:1339–1344PubMedCrossRefGoogle Scholar
  13. 13.
    Fitzpatrick A, Banner N, Cheng A et al (1993) Vasovagal reactions may occur after orthotopic heart transplantation. J Am Coll Cardiol 21:1132–1137PubMedCrossRefGoogle Scholar
  14. 14.
    Dickinson CJ (1993) Fainting precipitated by collapse firing of venous baroreceptors. Lancet 342:970–972PubMedCrossRefGoogle Scholar
  15. 15.
    Lee TM, Su SF, Chen MF et al (1996) Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 78:480–482PubMedCrossRefGoogle Scholar
  16. 16.
    Moya A, Permanyer-Miraldo G, Sagrista-Savleda J et al (1995) Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 25:65–69PubMedCrossRefGoogle Scholar
  17. 17.
    Raviele A, Brignole M, Sutton R et al, for the Vasovagal Syncope International Study Investigators (1999) Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope. A double-blind, randomised placebo-controlled trial. Circulation 99:1452–1457PubMedCrossRefGoogle Scholar
  18. 18.
    Ward CR, Gray JC, Gilroy JJ, Kenny RA (1998) Midodrine: a role in the management of neurocardiogenic syncope. Heart 79:45–49PubMedGoogle Scholar
  19. 19.
    Natale A, Beheiry S, Tomassoni GF et al (1999) Randomized placebo control assessment of midodrine in the treatment of neurocardiogenic syncope. J Am Coll Cardiol 33:269A (abstr)Google Scholar
  20. 20.
    Zeng C, Zhu Z, Liu G et al (1998) Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally-mediated syncope. Am Heart J 136:852–858PubMedCrossRefGoogle Scholar
  21. 21.
    Di Girolamo E, Di Forio C, Sabatini P et al (1999) Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomised, double-blind, placebo-controlled study. J Am Coll Cardiol 33:1227–1230PubMedCrossRefGoogle Scholar
  22. 22.
    Petersen M, Williams TR, Gordon C et al (2000) The normal response to prolonged passive head-up tilt testing. Heart 84:509–514PubMedCrossRefGoogle Scholar
  23. 23.
    Connolly SJ, Sheldon RS, Roberts RS, Gent M (1999) The North American Vasovagal Pacemaker Study. A randomised trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33:16–20PubMedCrossRefGoogle Scholar
  24. 24.
    Sheldon R, Rose S (2001) Components of clinical trials for vasovagal syncope. Europace 3:233–240PubMedCrossRefGoogle Scholar
  25. 25.
    Malik P, Koshman ML, Sheldon R, Malik P (1997) Timing of first syncope recurrence predicts syncope frequency following a positive tilt table test. J Am Coll Cardiol 29:1284–1289PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2002

Authors and Affiliations

  • R. Sutton
    • 1
  1. 1.Royal Brompton and Chelsea & Westminster HospitalsLondonUK

Personalised recommendations